a year ago
AMLX
AnalystsAndrew FeinAndrew Fein's Stock Forecasts
AnalystsAndrew Fein
Analyst Ranking
Top 30%
#1463 out of 4868 analysts
Average Return
+0.14%
Win Rate
41%251 out of 613
Risk vs Reward
Poor
Good
Andrew Fein's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings IncCRBP | +1,500.00% | $2.52 | $40.32 | 2023-03-07 - 2024-03-07 | Buy |
Corbus Pharmaceuticals Holdings IncCRBP | +570.73% | $3.28 | $22.00 | 2023-02-13 - 2024-02-13 | Buy |
C4 Therapeutics IncCCCC | +300.71% | $1.40 | $5.61 | 2023-11-01 - 2024-11-01 | Buy |
Proqr Therapeutics NvPRQR | +256.78% | $0.58 | $2.08 | 2022-05-08 - 2023-05-08 | Buy |
Bellerophon Therapeutics IncBLPH | +234.33% | $10.05 | $33.60 | 2017-01-19 - 2018-01-19 | Buy |
Andrew Fein Analyst Color
Get additional color on Andrew Fein's coverage of popular stocks
Andrew Fein's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Palvella Therapeutics IncPVLA | 6 | Buy | $38.00 | +56.51% | Reiterates | a day ago |
Immunitybio IncIBRX | 2 | Buy | $8.00 | +218.73% | Reiterates | 3 days ago |
Neurocrine Biosciences IncNBIX | 17 | Buy | $168.00 | +56.00% | Maintains | 9 days ago |
Insmed IncINSM | 14 | Buy | $90.00 | +25.00% | Reiterates | 9 days ago |
Structure Therapeutics IncGPCR | 4 | Buy | $80.00 | +196.30% | Maintains | 9 days ago |
Arvinas IncARVN | 17 | Buy | $81.00 | +742.00% | Reiterates | 24 days ago |
I MabIMAB | 12 | Buy | $7.00 | +644.68% | Maintains | a month ago |
Ac Immune SaACIU | 14 | Buy | $16.00 | +824.86% | Reiterates | a month ago |
Keros Therapeutics IncKROS | 13 | Buy | $40.00 | +177.01% | Reiterates | a month ago |
Acumen Pharmaceuticals IncABOS | 11 | Buy | $11.00 | +873.45% | Maintains | a month ago |
Savara IncSVRA | 12 | Buy | $6.00 | +87.50% | Reiterates | a month ago |
Zentalis Pharmaceuticals IncZNTL | 18 | Buy | $10.00 | +604.23% | Reiterates | a month ago |
Wave Life Sciences LtdWVE | 12 | Buy | $22.00 | +184.97% | Reiterates | a month ago |
Liquidia CorpLQDA | 11 | Buy | $29.00 | +107.59% | Reiterates | a month ago |
Stoke Therapeutics IncSTOK | 13 | Buy | $47.00 | +381.56% | Reiterates | a month ago |
Avidity Biosciences IncRNA | 4 | Buy | $72.00 | +120.52% | Reiterates | a month ago |
Dyne Therapeutics IncDYN | 10 | Buy | $46.00 | +290.16% | Reiterates | a month ago |
Sutro Biopharma IncSTRO | 12 | Hold | $2.00 | +90.48% | Downgrades | a month ago |
Vigil Neuroscience IncVIGL | 13 | Buy | $14.00 | +566.67% | Maintains | 2 months ago |
Kalvista Pharmaceuticals IncKALV | 14 | Buy | $20.00 | +45.24% | Reiterates | 2 months ago |
Proqr Therapeutics NvPRQR | 11 | Buy | $12.00 | +622.89% | Maintains | 2 months ago |
Foghorn Therapeutics IncFHTX | 14 | Buy | $13.00 | +209.52% | Reiterates | 2 months ago |
Protara Therapeutics IncTARA | 14 | Buy | $23.00 | +557.14% | Reiterates | 2 months ago |
Kamada LtdKMDA | 10 | Buy | $11.00 | +70.02% | Reiterates | 2 months ago |
Tscan Therapeutics IncTCRX | 13 | Buy | $15.00 | +834.58% | Reiterates | 2 months ago |
Amylyx Pharmaceuticals IncAMLX | 19 | Buy | $12.00 | +134.83% | Reiterates | 2 months ago |
Merus NvMRUS | 16 | Buy | $85.00 | +86.77% | Reiterates | 2 months ago |
Catalyst Pharmaceuticals IncCPRX | 14 | Buy | $35.00 | +44.09% | Reiterates | 2 months ago |
Kymera Therapeutics IncKYMR | 7 | Buy | $60.00 | +75.08% | Maintains | 2 months ago |
Denali Therapeutics IncDNLI | 17 | Buy | $87.00 | +422.52% | Maintains | 2 months ago |
Acadia Pharmaceuticals IncACAD | 17 | Buy | $27.00 | +84.93% | Reiterates | 2 months ago |
United Therapeutics CorpUTHR | 12 | Buy | $425.00 | +40.22% | Reiterates | 2 months ago |
Alector IncALEC | 9 | Buy | $7.00 | +483.33% | Reiterates | 2 months ago |
Fulcrum Therapeutics IncFULC | 15 | Hold | $4.00 | +3.90% | Reiterates | 2 months ago |
Biocryst Pharmaceuticals IncBCRX | 7 | Buy | $30.00 | +238.98% | Reiterates | 2 months ago |
Pepgen IncPEPG | 10 | Buy | $16.00 | +919.11% | Reiterates | 2 months ago |
Prothena Corp Public Ltd CoPRTA | 15 | Buy | $48.00 | +421.74% | Reiterates | 2 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 7 | Buy | $75.00 | +904.02% | Reiterates | 2 months ago |
Blueprint Medicines CorpBPMC | 15 | Buy | $135.00 | +50.84% | Reiterates | 3 months ago |
Biogen IncBIIB | 16 | Buy | $241.00 | +99.04% | Maintains | 3 months ago |
Vertex Pharmaceuticals IncVRTX | 20 | Buy | $550.00 | +7.95% | Reiterates | 3 months ago |
Cg Oncology IncCGON | 1 | Buy | $75.00 | +178.40% | Reiterates | 4 months ago |
Annexon IncANNX | 14 | Buy | $30.00 | +1,512.90% | Reiterates | 4 months ago |
Syros Pharmaceuticals IncSYRS | 16 | Hold | $1.00 | +754.70% | Downgrades | 6 months ago |
Dbv Technologies SaDBVT | 10 | Buy | $35.00 | +288.46% | Maintains | 6 months ago |
Unity Biotechnology IncUBX | 7 | Buy | $8.00 | +607.96% | Reiterates | 9 months ago |
C4 Therapeutics IncCCCC | 6 | Buy | $7.00 | N/A | Maintains | a year ago |
Deciphera Pharmaceuticals IncDCPH | 10 | Buy | $30.00 | N/A | Maintains | 2 years ago |
Pulmatrix IncPULM | 5 | Buy | $10.00 | N/A | Reiterates | 2 years ago |
Theseus Pharmaceuticals IncTHRX | 5 | Buy | $9.00 | N/A | Maintains | 2 years ago |
Bellerophon Therapeutics IncBLPH | 4 | Buy | $2.00 | N/A | Maintains | 2 years ago |
Bellus Health IncBLU | 5 | Buy | $20.00 | N/A | Reiterates | 2 years ago |
Seagen IncSGEN | 5 | Buy | $180.00 | N/A | Reiterates | 2 years ago |
Mei Pharma IncMEIP | 3 | Buy | $40.00 | N/A | Maintains | 2 years ago |
Matinas Biopharma Holdings IncMTNB | 1 | Buy | $150.00 | N/A | Reiterates | 2 years ago |
Epizyme IncEPZM | 4 | Buy | $6.00 | N/A | Maintains | 3 years ago |
Rubius Therapeutics IncRUBY | 3 | Buy | $8.00 | N/A | Maintains | 3 years ago |
Eloxx Pharmaceuticals IncELOX | 5 | Hold | $20.00 | N/A | Maintains | 3 years ago |
Amarin Corp PLCAMRN | 1 | Hold | $60.00 | N/A | Downgrades | 3 years ago |
Global Blood Therapeutics IncGBT | 2 | Buy | $65.00 | N/A | Maintains | 3 years ago |
Aldeyra Therapeutics IncALDX | 1 | Buy | $15.00 | N/A | Assumes | 3 years ago |
Aprea Therapeutics IncAPRE | 3 | Hold | $40.00 | N/A | Maintains | 3 years ago |
Disc Medicine IncIRON | 2 | Hold | $2.00 | N/A | Downgrades | 3 years ago |
Quince Therapeutics IncQNCX | 4 | Buy | $15.00 | N/A | Maintains | 3 years ago |
Opus Genetics IncIRD | 1 | Buy | $26.00 | N/A | Initiates Coverage On | 3 years ago |
Kineta IncKANT | 1 | Buy | $39.00 | N/A | Initiates Coverage On | 4 years ago |
Translate Bio IncTBIO1 | 3 | Buy | $504.00 | N/A | Maintains | 4 years ago |
Aimmune Therapeutics IncAIMT | 2 | Hold | $15.00 | N/A | Reiterates | 5 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Buy | $75.00 | N/A | Reiterates | 5 years ago |
Concert Pharmaceuticals IncCNCE | 3 | Buy | $26.00 | N/A | Maintains | 7 years ago |
Steadymed LtdSTDY | 1 | Buy | $15.00 | N/A | Reiterates | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.